FINANCIAL RELEASES

Total Invisalign® patients surpasses 18 million globally, including over 5 million teens and kids Q2'24 total revenues of $1,028.5 million , increased 3.1% sequentially, and increased 2.6% year-over-year, and Q2'24 diluted net income per share was $1.28 , or $2.41 on a non-GAAP diluted basis Q2'24

Q1 ' 24 total revenues up 5.8% year-over-year including revenue growth of 3.5% from Clear Aligners and growth of 17.5% from Imaging Systems and CAD/CAM Services Q1'24 total revenues of $997.4 million , increased 5.8% year-over-year, and diluted net income per share of $1.39 , non-GAAP diluted net

Unveils Next-Generation iTero Lumina™ Intraoral Scanner Featuring a 3X Wider Field of Capture 1 in a 50% Smaller Wand 2 that Delivers Faster Scanning, Higher Accuracy 3 , and Superior Visualization 4 for Greater Practice Efficiency Q4 and FY2023 total revenues up 6.1% year over year and up 3.4%

Q3’23 record clear aligner shipments to teenage patients increased 9.9% sequentially and 8.4% year over year, driven by continued strength from Invisalign First™ Company expects to repurchase up to $250.0 million of its common stock in Q4’23 Q3'23 total revenues of $960.2 million , increased 7.8%

TEMPE, Ariz. --(BUSINESS WIRE)--Oct. 4, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Better than expected revenues and operating margins reflect improving trends across regions Q2’23 Clear Aligner cases for teenagers increased 7% sequentially and 10% year over year, driven by momentum in both Submitters and Utilization and continued growth from Invisalign First™ Q2'23 total

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Delivers revenue and EPS ahead of expectations, with total Invisalign® patients treated surpassing 15 million globally Completes May 13, 2021   $1 Billion Stock Repurchase Program Q1'23 total revenues of $943.1 million , increased 4.6% sequentially, and diluted net income per share of $1.14 ,

TEMPE, Ariz. --(BUSINESS WIRE)--Apr. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Q4 total revenues of $901.5 million and 2022 total revenues of $3.7 billion Board of Directors has authorized a new $1 billion stock repurchase program, to succeed the current $1 billion program that is expected to be completed in Q2 2023   2022 total revenues of $3.7 billion , Clear Aligner

TEMPE, Ariz. --(BUSINESS WIRE)--Jan. 3, 2023-- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Company delivering on innovation roadmap; expanding geographically with first EMEA manufacturing facility; and celebrating 14 millionth Invisalign patient milestone Q3'22 total revenues of $890.3 million , and diluted net income per share of $0.93 Q3’22 revenues were unfavorably impacted by foreign

TEMPE, Ariz. --(BUSINESS WIRE)--Oct. 3, 2022-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Company operating well through unprecedented global economic headwinds and continued impacts of COVID-19 variants in certain markets Q2'22 total revenues of $969.6 million were down slightly sequentially and year over year Q2’22 revenues were unfavorably impacted by foreign exchange of

TEMPE, Ariz. --(BUSINESS WIRE)--Jul. 5, 2022-- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and

Joe Hogan, president and CEO, intends to personally purchase $2.0 million of Align’s common stock TEMPE, Ariz., May 02, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of

Commemorates 25 years of smiles and innovation through doctor-directed care with major milestones including 217K Invisalign trained doctors, 12.8M Invisalign patients, 73K iTero scanners, and 49K exocad software licenses Q1'22 total revenues of $973.2 million, compared to $894.8 million in Q1'21

TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and

Strengthens Align digital platform with major installed base milestones including 12M Invisalign patients, 68K iTero scanners, and 47K exocad software licenses 2021 total revenues up 59.9% to a record $4.0 billion, operating margin of 24.7%, in line with guidance 2021 revenue growth for the second

TEMPE, Ariz., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative